End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,720 KRW | -2.11% | -11.32% | -29.55% |
2023 | U2Bio Co., Ltd. has filed an IPO. | CI |
2020 | Chang Moo Jeon acquired 8.5% stake in U2Bio CO. LTD. from MAC Fund, L.P. (Class B), a fund managed by M-Venture Investment, Inc. for KRW 1.6 billion. | CI |
Income Statement Evolution (Annual data)
Fiscal Period: |
---|
Balance Sheet Analysis
Fiscal Period: |
---|
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.55% | 3.02Cr | |
+25.01% | 8.86TCr | |
-22.75% | 7.66TCr | |
+3.24% | 2.69TCr | |
-8.76% | 1.75TCr | |
+1.00% | 1.71TCr | |
+0.23% | 1.54TCr | |
+78.95% | 1.32TCr | |
+71.14% | 1.32TCr | |
-24.74% | 1.3TCr |
- Stock Market
- Equities
- A221800 Stock
- Financials U2Bio Co., Ltd.